Clinical trial Recruiting at 1 site Interventional Ages 12 to 80

Digital Health Education to Improve Heart Health Across Different Socioeconomic Groups (e-DUCASS Advance)

Official title: Educational Strategy in Populations of Different Socioeconomic Status to Improve Cardiovascular Health Through a Digital Health Literacy Program: e-DUCASS Advance

Run by Maimónides Biomedical Research Institute of Córdoba · NCT07835386 · Data updated 2026-11-12

This study tests a 24-month digital health education program to see if it can improve cardiovascular health among people in Córdoba, Spain from varied socioeconomic backgrounds, by delivering weekly online content to families.

More Cardiovascular Health trials

Quick facts

Study typeInterventional
Ages12 Years to 80 Years
SexAll
Enrollment600 (estimated)
SponsorMaimónides Biomedical Research Institute of Córdoba
Academic / other
Locations1 site (Córdoba)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedDecember 15, 2028
Study endsDecember 15, 2028
Registry record updatedSeptember 22, 2026
Trial IDNCT07835386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 12–79 living in Córdoba who are willing to participate with at least one other household member and have access to online materials.

Probably not a fit

Participants who do not engage with the digital program or lack access to digital tools may see little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 24-month, cluster-randomized trial conducted in Córdoba, Spain. Household members are randomized together to either receive a digital health education program or serve as controls. The intervention delivers weekly digital content via web or messaging platforms, including videos, infographics, knowledge checks, and motivational activities, following a basic initial health education workshop. Participants range in age from 12 to 79 and include both healthy individuals and those with stable medical conditions. The study uses stratified randomization by socioeconomic status and household type to minimize contamination across groups.

Why it matters

Potential benefit: If successful, the program could improve cardiovascular health and health literacy across diverse socioeconomic groups.

How similar studies have gone: Previous digital health literacy interventions have shown potential in improving health behaviors, though results vary by population and setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 12 to 79 years.
* Provision of written informed consent. For participants younger than 18 years, written informed consent from a parent or legal guardian and assent from the participant, when appropriate, are required.
* Both healthy individuals and individuals with stable medical conditions are eligible. No specific disease or cardiovascular risk factor is required for participation.

Exclusion Criteria:

* Life expectancy of less than 5 years.
* Inability to complete the study intervention or scheduled study procedures, either independently or, when applicable, with support from a parent, legal guardian, or household member.
* Serious or unstable medical conditions that could limit participation, follow-up, or survival, including hypertension or diabetes with target-organ damage affecting survival, disabling clinical manifestations of cerebrovascular disease, severe psychiatric illness, advanced chronic kidney disease, chronic liver disease, cancer under active treatment, severe or very severe chronic obstructive pulmonary disease, endocrine disease at risk of decompensation, or clinically significant chronic gastrointestinal disease.

Where it's running

  • Instituto Maimónides de Investigación Biomédica de Córdoba
    Córdoba, Spain
    Recruiting

Study contacts

  • Principal investigator: Pablo Pérez Martínez, Professor, PhD, MD — Instituto Maimónides de Investigación Biomédica de Córdoba
  • Study coordinator: e-DUCASS Advance Study Team
  • Email: educass.advance@imibic.org
  • Phone: +34 680 761 975

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.